Looking into cognitive impairment in Primary-Progressive Multiple Sclerosis.
Petracca M, et al. Eur J Neurol. 2017. Show full citation Abstract BACKGROUND: Cognitive impairment in primary-progressive multiple sclerosis (PP-MS) is…
Print Global Experts Publish Recommendations for Overcoming Challenges to Improve Clinical Trials in Progressive MS
October 18, 2017 A special issue of Multiple Sclerosis Journal, sponsored by the International Progressive MS Alliance, has been published, containing ten…
Stuart Schlossman
Long-term disability progression in primary progressive multiple sclerosis: a 15-year study.
Rocca MA, et al. Brain. 2017. Show full citation Abstract Prognostic markers of primary progressive multiple sclerosis evolution are needed.…
Stuart Schlossman
Ocrevus Phase 3 Trial Will Explore How Treatment Works by Viewing Changes in Spinal Fluid
…
Stuart Schlossman
Primary Progressive MS: Myths vs. Facts
…
Stuart Schlossman
Genetics of primary progressive multiple sclerosis
…
Stuart Schlossman
Trailblazing MS doctor William Sheremata dies just after drug’s FDA approval
…
Stuart Schlossman
Press Release: Genentech’s OCREVUS (ocrelizumab) for people with relapsing or primary progressive forms of multiple sclerosis (MS)
…
Stuart Schlossman
RESERVE (RSVP) Seating for Unique Multiple Sclerosis Spanish event in Los Angeles, Ca
…
Stuart Schlossman
Ocrevus Seen in Phase 3 Trials to Benefit Both Primary Progressive and Relapsing MS Patients
…
Stuart Schlossman
